147 related articles for article (PubMed ID: 2941608)
21. Phase I trial of alpha-difluoromethyl ornithine (DFMO) and methylglyoxal bis (guanylhydrazone) (MGBG) in patients with advanced prostatic cancer.
Herr HW; Warrel RP; Burchenal JH
Urology; 1986 Dec; 28(6):508-11. PubMed ID: 3097903
[TBL] [Abstract][Full Text] [Related]
22. [Therapy with inhibitors of polyamine biosynthesis in refractory prostatic carcinoma. An experimental and clinical study].
Dunzendorfer U; Knöner M
Onkologie; 1985 Aug; 8(4):196-200. PubMed ID: 2419811
[TBL] [Abstract][Full Text] [Related]
23. Regulation of epidermal proliferation in mouse epidermis by combination of difluoromethyl ornithine (DFMO) and methylglyoxal bis(guanylhydrazone) (MGBG).
McCullough JL; Peckham P; Klein J; Weinstein GD; Jenkins JJ
J Invest Dermatol; 1985 Dec; 85(6):518-21. PubMed ID: 3934288
[TBL] [Abstract][Full Text] [Related]
24. Antigrowth effect of some inhibitors of polyamine synthesis on transplantable prostate cancer.
Dunzendorfer U; Relyea NM; Kleinert E; Balis ME; Whitmore WF
Oncology; 1983; 40(1):57-62. PubMed ID: 6401860
[TBL] [Abstract][Full Text] [Related]
25. Synergistic antileukemic effect of two polyamine synthesis inhibitors. Host survival and cell-cycle kinetic analysis.
Ask A; Persson L; Oredsson SM; Heby O
Int J Cancer; 1986 Mar; 37(3):465-70. PubMed ID: 3081454
[TBL] [Abstract][Full Text] [Related]
26. Alterations in bone marrow and blood mononuclear cell polyamine and methylglyoxal bis(guanylhydrazone) levels: phase I evaluation of alpha-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) treatment of human hematological malignancies.
Maddox AM; Freireich EJ; Keating MJ; Haddox MK
Cancer Res; 1988 Mar; 48(5):1367-73. PubMed ID: 3124958
[TBL] [Abstract][Full Text] [Related]
27. Polyamines increase in human peripheral blood and bone marrow mononuclear cells following administration of methylglyoxal bis(guanylhydrazone).
Maddox AM; Keating MJ; Freireich EJ; Haddox MK
Chemotherapy; 1988; 34(5):419-29. PubMed ID: 3141118
[TBL] [Abstract][Full Text] [Related]
28. Phase I study of alpha-difluoromethylornithine and methyl-GAG.
Splinter TA; Romijn JC
Eur J Cancer Clin Oncol; 1986 Jan; 22(1):61-7. PubMed ID: 3082642
[TBL] [Abstract][Full Text] [Related]
29. Antigrowth effect of polyamine biosynthesis inhibitors on the Dunning R 3327-G prostatic tumor.
Herr HW; Kleinert EL
Prostate; 1984; 5(4):439-44. PubMed ID: 6429652
[TBL] [Abstract][Full Text] [Related]
30. Modulation of the tissue disposition of methylglyoxal bis(guanylhydrazone) in mice by polyamine depletion and by polyamine administration.
Kallio A; Seppänen P; Alhonen-Hongisto L; Jänne J
Cancer Res; 1983 Jan; 43(1):324-7. PubMed ID: 6401167
[TBL] [Abstract][Full Text] [Related]
31. Haematological cell proliferation and differentiation responses to perturbations of polyamine biosynthesis.
O'Conor GT; McCann PP; Wharton WW; Niskanen E
Cell Tissue Kinet; 1986 Sep; 19(5):539-46. PubMed ID: 3098430
[TBL] [Abstract][Full Text] [Related]
32. Experimental chemotherapy in a transplantable renal adenocarcinoma. I: Effects of some inhibitors of polyamine synthesis.
Dunzendorfer U; Kleinert E; Whitmore WF
Urol Int; 1983; 38(3):162-5. PubMed ID: 6408777
[TBL] [Abstract][Full Text] [Related]
33. A standardized method of using nude mice for the in vivo screening of antitumor drugs for human tumors.
Imaizumi M; Kondo T; Taguchi T; Hattori T; Abe O; Kitano M; Wakui A
Surg Today; 1993; 23(5):412-9. PubMed ID: 8324334
[TBL] [Abstract][Full Text] [Related]
34. Differential effect of alpha-difluoromethylornithine on the in vivo uptake of 14C-labeled polyamines and methylglyoxal bis(guanylhydrazone) by a rat prostate-derived tumor.
Heston WD; Kadmon D; Covey DF; Fair WR
Cancer Res; 1984 Mar; 44(3):1034-40. PubMed ID: 6420052
[TBL] [Abstract][Full Text] [Related]
35. Effects of alpha-difluoromethylornithine and recombinant interferon-alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice.
Heston WD; Fleischmann J; Tackett RE; Ratliff TL
Cancer Res; 1984 Aug; 44(8):3220-5. PubMed ID: 6430546
[TBL] [Abstract][Full Text] [Related]
36. Effects of inhibitors of polyamine biosynthesis on the growth and melanogenesis of murine melanoma cells.
Käpyaho K; Sinervirta R; Jänne J
Cancer Res; 1985 Apr; 45(4):1444-8. PubMed ID: 3919940
[TBL] [Abstract][Full Text] [Related]
37. Long-term maintenance therapy of established human small cell variant lung carcinoma implants in athymic mice with a cyclic regimen of difluoromethylornithine.
Luk GD; Abeloff MD; McCann PP; Sjoerdsma A; Baylin SB
Cancer Res; 1986 Apr; 46(4 Pt 1):1849-53. PubMed ID: 3004708
[TBL] [Abstract][Full Text] [Related]
38. Sequential inhibition of polyamine synthesis. A phase I trial of DFMO (alpha-difluoromethylornithine) and methyl-GAG [methylglyoxal-bis(guanylhydrazone)].
Warrell RP; Coonley CJ; Burchenal JH
Cancer Chemother Pharmacol; 1983; 11(2):134-6. PubMed ID: 6414731
[TBL] [Abstract][Full Text] [Related]
39. Difluoromethylornithine enhances the uptake of methylglyoxal-bis(guanylhydrazone) prior to inhibiting leukemic cell proliferation.
Maddox AM; Orengo I; Haddox MK
Chemotherapy; 1987; 33(2):110-22. PubMed ID: 3105968
[TBL] [Abstract][Full Text] [Related]
40. CNS toxicity and CSF pharmacokinetics of intraventricular DFMO and MGBG in beagle dogs.
Levin VA; Byrd D; Campbell J; Davis RL; Borcich JK
Cancer Chemother Pharmacol; 1984; 13(3):200-5. PubMed ID: 6435895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
